title: [Clinical review of pseudoporphyria].
abstract: Pseudoporphyria is a photosensitive bullous disease, which resembles porphyria cutanea tarda. Normal porphyrin levels in urine, stool and blood define pseudoporphyria. Pseudoporphyria is associated with chronic renal failure, haemodialysis, a variety of drugs (e.g. naproxen, nabumetone, furosemide, ciprofloxacin, voriconazole, acitretin), tanning beds and UVA exposure. Treatment consists of UV protection and cessation of suspected agents. Patients in haemodialysis can benefit from treatment with N-acetylcysteine or glutathione.
authors: Medicinsk Afdeling, Odense Universitetshospital, Svendborg Sygehus, Valdemarsgade 53, 5700 Svendborg. marie@juulvelander.dk/marie.juul.velander@rsyd.dk.
authors: Marie Juul
authors: MJ
authors: Velander
authors: Sunna
authors: S
authors: Þorsteinsdóttir
authors: Anette
authors: A
authors: Bygum
mesh_terms: D003875:Drug Eruptions / Q000209:etiology; D006801:Humans; D017119:Porphyria Cutanea Tarda / Q000175:diagnosis; D011166:Porphyrins / Q000032:analysis; D012872:Skin Diseases, Vesiculobullous / Q000175:diagnosis / Q000209:etiology / Q000473:pathology / Q000628:therapy; D014466:Ultraviolet Rays / Q000009:adverse effects
chemical_list: D011166:Porphyrins